NFL News: Andy Reid's Chiefs sign a key veteran to help Patrick Mahomes, Travis Kelce The Ocean Has Massive Energy Reserves.

The CEO of pharmaceuticals giant Roche said authorities should block the takeover of contract drug manufacturer Catalent by ...

Roche confirmed its profit outlook for the year after its eye drug Vabysmo, multiple-sclerosis treatment Ocrevus and ...

The CEO of Roche said he has been informed that more cases of mpox infection have occurred in Europe than previously reported ...

Roche's third-quarter sales gained a currency-adjusted 9%, beating market expectations, on higher prescriptions of ...

After forming a gene therapy partnership with Dyno Therapeutics in 2020, Roche is back for more. | In a new deal potentially ...

George Church-founded Dyno Therapeutics Inc. is adding to its list of pharma deals by signing a second research collaboration ...

With an upfront payment of $50 million from Roche, the partnership will leverage Dyno Therapeutics’ in vivo gene therapy ...

By squeezing Regeneron’s Eylea, eye disease drug Vabysmo has become one of the biggest growth drivers for Roche. | Despite ...

Roche’s chronic cough program has sputtered to a halt. The drugmaker, which axed the program after the drug candidate ...

Win Some Lose Some lived up to his name by following up a loss with a victory for the third time in a row when he pounced ...

Roche reported a 9% increase in third-quarter sales, driven by strong performance from Ocrevus and Vabysmo. Roche also raised ...